Digital Health Startups

Mirae is a mobile application that helps people with inflammatory bowel disease understand their condition, track clinical and daily experience data, and prepare for conversations with healthcare providers. The app combines patient-reported symptoms and clinical information to give people with IBD a clearer picture of their disease without replacing clinical judgment.

1 investor

Miraka provides clinician-led cardiac care delivered at home, using continuous real-time monitoring of biometrics such as heart rhythm, blood oxygen, and blood pressure to detect emerging risks and escalate treatment early. It serves cardiac patients between hospital visits, aiming to reduce hospital readmissions, and works via physician referrals at health systems.

1 investor

Miranza operates a network of ophthalmology clinics in Spain specializing in eye care and vision health, offering treatments such as cataract surgery and intraocular lens implants. It serves patients across more than 30 clinics in cities including Barcelona, Madrid, Alicante, Tenerife, and Seville.

1 investor

Mireca develops treatments for rare, inherited retinal degenerations based on scientific research originating from the EU-funded DRUGSFORD project. The company translates basic research into therapeutic candidates targeting photoreceptor degeneration diseases such as retinitis pigmentosa and achromatopsia.

1 investor

Miri offers a subscription-based health program aimed at GLP-1 medication users, helping providers retain customers through ongoing monthly engagement. The product is positioned to improve program retention and generate recurring revenue for the businesses that deploy it.

1 investor

Mishe operates a direct payor platform that connects employers and members directly with health systems and providers, enabling same-day payments to providers and zero-cost network benefits for members. The platform handles direct contracting, care coordination, and claims processing, including pre-funded treatments with same-day EFT remittance.

1 investor

Mission Driven Tech develops medical devices and educational content focused on cervical and uterine cancer treatment. The company offers brachytherapy devices for gynecological cancers and outcome research resources for healthcare professionals.

1 investor

MKCL offers educational products and services focused on bridging the digital divide, including IT certification courses, test preparation platforms, and a secure assessment and certification framework used by universities and government institutions.

1 investor

MLA Diagnostics develops a melanoma diagnostic test based on DNA methylation biomarkers to improve patient risk stratification and treatment decisions. The company serves oncology practices and pathology labs in the cancer diagnostics market.

1 investor

Minnesota Medical Technologies develops and manufactures continence care products, specifically fecal incontinence management devices for individual patients. The company is based in Stewartville, Minnesota, and leverages over 30 years of expertise in silicone technology and medical device manufacturing.

1 investor

PETAON Forecaster is an AI-powered infrastructure monitoring platform that detects anomalies, predicts failures, and analyzes root causes in ICT systems by processing metrics and logs through machine learning algorithms. It serves enterprise IT operations teams managing complex computing infrastructure.

1 investor

Mobile Health provides a suite of self-care pathways and digital health solutions delivered through employer wellbeing programs to help employees manage their health, and to help companies lower healthcare costs and improve employee wellbeing. It offers virtual care aimed at driving engagement and better health outcomes for workforces.

1 investor

MobileHelp provides medical alert systems and wearable safety devices for older adults, including on-the-go GPS pendants and in-home base stations connected to a 24/7 US-based monitoring center. Its devices offer one-touch SOS, fall detection, and activity tracking over AT&T's cellular network without requiring a landline or contract.

1 investor

Model Health is a software company that uses artificial intelligence and smartphone video to perform biomechanical analysis of human movement. The platform serves physiotherapists, medical staff, coaches, and sports organizations seeking clinical-grade movement insights for injury prevention, rehabilitation, and performance optimization.

1 investor

MODJAW builds a 4D digital dental technology that captures and integrates jaw movement in real time into the digital workflow, used by dentists, prosthodontists, and orthodontists for diagnosis, treatment planning, and restoration design. The system supports full-mouth rehabilitations, TMJ dysfunction diagnostics, and prosthetic treatments.

1 investor

ModMed develops an electronic health record platform for allergy practices, led by board-certified medical professionals who design clinical content and workflows.

1 investor

Modulight develops a platform to treat severe neurological diseases through scientific innovation and clinical expertise.

1 investor

Moggie is a digital health platform that helps cat owners track and understand their pets' wellbeing by identifying behavioral and health changes. The service is designed for pet owners who want to monitor their cats' health with greater confidence and early detection of potential issues.

1 investor

MoldCo is a healthcare technology platform connecting patients with mold-trained providers to diagnose and treat mold-related illness through virtual care, testing, and personalized treatment protocols. The service is available across the United States and offers symptom assessment, laboratory testing, and ongoing medical support for individuals experiencing health complications from mold exposure.

1 investor

Moleculera Labs offers the Autoimmune Brain Panel, a diagnostic blood test that identifies autoimmune dysfunction in patients with treatment-resistant neuropsychiatric and behavioral symptoms. The test measures autoimmune antibodies targeting brain receptors to help clinicians distinguish autoimmune-driven conditions from primary psychiatric or neurologic disorders.

1 investor

Moleculera Biosciences is a precision medicine company that develops blood-based immune-mediated autoantibody testing panels and AI-driven diagnostic tools to identify immune dysfunction underlying chronic neuropsychiatric and cardiovascular disorders, as well as Alzheimer's disease. The company operates an integrated platform combining diagnostic panels, a biorepository with bioinformatics, and a therapeutic target identification program.

1 investor

MoleMap provides skin cancer detection and diagnosis services, including full-body mole mapping, dermatologist-diagnosed skin checks, imaging with ongoing monitoring, and skin cancer treatment. It serves individuals and workplaces through clinics in New Zealand and Australia, with additional GP referral and workplace screening programs.

1 investor

MoleSense is a Switzerland-based company whose website references future health-related products, applications, wearable devices, biomarker and clinical data processing. The page is a privacy policy and gives limited detail, but suggests a focus on health monitoring or diagnostics involving wearables and biomarker data.

1 investor

Molly Health builds a unified interface platform that integrates claims data, benefit decisioning logic, and consumer-facing tools to guide patients toward appropriate and accessible care decisions across fragmented health insurance systems.

1 investor